Vesugen 20 mg

Steroids Dragon Pharma Peptides

$70.00

Dragon Pharma Vesugen 20 mg – Synthetic Tripeptide for Vascular Research

✔ Synthetic KED tripeptide bioregulator ✔ Khavinson peptide class compound ✔ Studied for vascular endothelial function ✔ USA domestic shipping available

Dragon Pharma Vesugen 20 mg is a synthetic tripeptide bioregulator with the amino acid sequence Lys-Glu-Asp (KED). Developed within the well-established Khavinson peptide framework, this compound has been investigated in laboratory settings for its potential effects on vascular endothelial cells, microcirculation, and age-related changes in blood vessel walls.

Each vial contains 20 mg of lyophilized Vesugen in a 2 mL format, requiring reconstitution with bacteriostatic water before use. Vesugen represents a targeted research tool for investigating vascular biology, endothelial function, and the molecular mechanisms underlying vascular aging and microcirculatory health. For related research compounds, explore our peptides category and specifically Cardiogen for complementary cardiovascular research applications.

What Makes Vesugen Valuable in Research?

Vesugen belongs to a class of short-chain peptides known for their tissue-specific bioregulatory properties. The KED sequence has been studied for its ability to influence cellular processes relevant to vascular health, including endothelial cell function, microcirculatory dynamics, and the vascular changes associated with aging. Its defined sequence and mechanism of action make it a practical tool for investigating the molecular basis of vascular regulation.

Researchers value Vesugen for its targeted approach to studying vascular biology. Its ability to modulate endothelial cell activity and microcirculation provides insights into the mechanisms that govern vascular health and age-related vascular changes. For investigators exploring other areas of vascular research, MOTS-C offers complementary research avenues in metabolic and vascular function studies.

Current scientific literature on Khavinson peptides, including Vesugen, can be accessed through the PubMed database, where researchers can review peer-reviewed studies on their biological activity and experimental applications.

Key Research Applications for Dragon Pharma Vesugen

✔ Investigation of vascular endothelial cell function
✔ Evaluation of microcirculation and blood flow dynamics
✔ Research on age-related vascular changes
✔ Studies of peptide bioregulation in vascular models
✔ Preclinical models of vascular health and aging

For Research Purposes Only

Vesugen 20 mg is intended for research use only and is not approved for human consumption. Proper handling, reconstitution, and experimental protocols are essential for reliable results. For studies on vascular repair, TB 500 provides additional research avenues in angiogenesis and tissue regeneration.

Dispatched within 24 hours in plain, discreet packaging.

Additional Information

Categories:

Steroids

Brand: Dragon Pharma

Manufacturer: Dragon Pharma

Dosage Info: <div class="tab-pane fade" id="offer-tabbody--dosage-and-usage" role="tabpanel"> <section class="tab-panel" id="panel-usage"> <h2>Dosage & Usage Guidelines</h2> <div class="info-card warning"> <p><strong>For research and laboratory use only.</strong> Dragon Pharma Vesugen 20 mg is a synthetic tripeptide bioregulator. Proper reconstitution, handling, and experimental design are essential for obtaining reliable data.</p> </div> <h3>Reconstitution Protocol</h3> <ul class="usage-highlights"> <li>✔ Use sterile bacteriostatic water for injection</li> <li>✔ Add appropriate volume to achieve desired concentration</li> <li>✔ Swirl gently to dissolve – do not shake vigorously</li> <li>✔ Store reconstituted solution at 2–8°C</li> </ul> <p>Reconstitute the lyophilized powder using bacteriostatic water to a concentration suitable for your research protocol. The 20 mg format allows for flexible dosing across a range of experimental models. Always use aseptic technique during preparation to maintain peptide integrity.</p> <h3>Typical Research Parameters</h3> <p>In research settings, Vesugen is typically administered via subcutaneous or intraperitoneal injection. Dosing schedules and concentrations vary widely depending on the experimental design, animal model, and specific research objectives.</p> <ul> <li>✔ Commonly used in vascular endothelial function studies</li> <li>✔ Often combined with histological and molecular analysis</li> <li>✔ Used to investigate microcirculation and vascular aging</li> <li>✔ Research models include vascular aging and microcirculatory paradigms</li> </ul> <h3>Factors to Consider in Research Protocols</h3> <ul> <li>Short-chain peptide with specific bioregulatory properties</li> <li>Reconstitution stability is limited; prepare fresh solutions for each use</li> <li>Individual variation in response may be observed across subjects</li> <li>Storage conditions significantly impact peptide stability</li> </ul> <div class="info-card"> <p><strong>Research note:</strong> Vesugen is part of the Khavinson peptide class, known for their tissue-specific bioregulatory effects. Its short KED sequence provides a defined molecular tool for investigating vascular endothelial function, microcirculation, and the molecular mechanisms underlying age-related changes in blood vessel walls.</p> </div> </section> </div>

Reviews:

(0 customer reviews)